SCHEMBL21921077

SCHEMBL21921077

CNc1nccc(C)c1Cl

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.40
ALDH1A1 P00352 3/20 0.40
TDP1 Q9NUW8 2/20 0.40
METAP2 P50579 1/20 0.40
METAP1 P53582 1/20 0.40
LMNA P02545 1/20 0.40
CCR1 P32246 1/20 0.37
CCR5 P51681 1/20 0.37
CCR8 P51685 1/20 0.37
LRRK2 Q5S007 3/20 0.36
CLCN2 P51788 1/20 0.36
NOS3 P29474 3/20 0.35
NOS2 P35228 3/20 0.35
CYP1A2 P05177 3/20 0.33
CYP3A4 P08684 3/20 0.33
RAB9A P51151 2/20 0.33
CYP2C19 P33261 2/20 0.33
CYP2D6 P10635 1/20 0.33
NPC1 O15118 1/20 0.33
GAA P10253 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21598402 0.81 NOS2 (0.39) KDM4EALDH1A1TDP1CCR1CCR5
SCHEMBL28576286 0.80 KDM4E (0.41) KDM4EALDH1A1TDP1METAP2METAP1
SCHEMBL26489431 0.78 CCR1 (0.33) KDM4EALDH1A1CCR1CCR5CCR8
SCHEMBL21921157 0.78 LRRK2 (0.46) KDM4ETDP1LMNACCR1CCR5
SCHEMBL13208006 0.77 NOS2 (0.48) KDM4EALDH1A1TDP1METAP2METAP1
SCHEMBL22440558 0.77 KDM4E (0.39) KDM4EALDH1A1TDP1METAP2METAP1
SCHEMBL19785451 0.77 KDM4E (0.39) KDM4EALDH1A1TDP1METAP2METAP1
SCHEMBL19785099 0.77 KDM4E (0.39) KDM4EALDH1A1TDP1METAP2METAP1
SCHEMBL31288549 0.75 KDM4E (0.38) KDM4EALDH1A1TDP1METAP2METAP1
SCHEMBL22440534 0.75 KDM4E (0.38) KDM4EALDH1A1TDP1METAP2METAP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230242551-A1 ISOTOPE-SUBSTITUTED SPIRO AROMATIC RING COMPOUND AND APPLICATION THEREOF ETERN BIOPHARMA (SHANGHAI) CO., LTD. (CN) 2023-08-03 US disclosed
US-20230242551-A1 ISOTOPE-SUBSTITUTED SPIRO AROMATIC RING COMPOUND AND APPLICATION THEREOF ETERN BIOPHARMA (SHANGHAI) CO., LTD. (CN) 2023-08-03 US disclosed
WO-2023072191-A1 PYRROLOPYRAZOLE SPIRO COMPOUND 正大天晴药业集团股份有限公司 2023-05-04 WO disclosed
WO-2022089406-A1 NITROGEN-CONTAINING FUSED HETEROCYCLIC COMPOUND, AND PREPARATION METHOD THEREFOR AND USE THEREOF 上海青煜医药科技有限公司 2022-05-05 WO disclosed
WO-2021115286-A1 SIX-MEMBERED AND FIVE-MEMBERED AROMATIC RING DERIVATIVE CONTAINING NITROGEN HETEROATOMS WHICH CAN BE USED AS SHP2 INHIBITOR 成都倍特药业股份有限公司 2021-06-17 WO disclosed
WO-2021028362-A1 SHP2 INHIBITORS IRBM S.P.A. (IT) 2021-02-18 WO disclosed
EP-3772513-A1 SHP2 INHIBITORS C.N.C.C.S. S.c.a.r.l. Collezione Nazionale Dei Composti Chimici e Centro Screening (IT) 2021-02-10 EP disclosed
WO-2020063760-A1 NOVEL HETEROCYCLIC DERIVATIVES USEFUL AS SHP2 INHIBITORS JACOBIO PHARMACEUTICALS CO., LTD. (CN) 2020-04-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230242551-A1 ISOTOPE-SUBSTITUTED SPIRO AROMATIC RING COMPOUND AND APPLICATION THEREOF SLCO1B1, SLCO1B3, SLCO2B1 KDM4E 4277/4885ALDH1A1 884/4885TDP1 2158/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.